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Cortical and Leptomeningeal Cerebrovascular Amyloid 
and White Matter Pathology in Alzheimer’s Disease
ALEX E ROHER,1 YU-MIN KUO,2 CHERA ESH,1 CARMEN KNEBEL,1 NICOLE WEISS,1
WALTER KALBACK,1 DEAN C LUEHRS,1 JENNIFER L CHILDRESS,1 THOMAS G BEACH,3
ROY O WELLER,4 AND TYLER A KOKJOHN5
Alzheimer’s disease (AD) is characterized by neurofibrillary tangles and by the accumulation of β-amyloid (Aβ) peptides in
senile plaques and in the walls of cortical and leptomeningeal arteries as cerebral amyloid angiopathy (CAA). There also is
a significant increase of interstitial fluid (ISF) in cerebral white matter (WM), the pathological basis of which is largely
unknown. We hypothesized that the accumulation of ISF in dilated periarterial spaces of the WM in AD correlates with the
severity of CAA, with the total Aβ load in the cortex and with Apo E genotype. A total of 24 AD brains and 17 nondement-
ed age-matched control brains were examined. CAA was seen in vessels isolated from brain by using EDTA-SDS lysis stained
by Thioflavin-S. Total Aβ in gray matter and WM was quantified by immunoassay, ApoE genotyping by PCR, and dilatation
of perivascular spaces in the WM was assessed by quantitative histology. The study showed that the frequency and severi-
ty of dilatation of perivascular spaces in the WM in AD were significantly greater than in controls (P < 0.001) and correlated
with Aβ load in the cortex, with the severity of CAA, and with ApoE ε4 genotype. The results of this study suggest that dilation
of perivascular spaces and failure of drainage of ISF from the WM in AD may be associated with the deposition of Aβ in the
perivascular fluid drainage pathways of cortical and leptomeningeal arteries. This failure of fluid drainage has implications
for therapeutic strategies to treat Alzheimer’s disease.
INTRODUCTION
Alzheimer’s disease (AD) is characterized clinically by dementia
and pathologically by the accumulation of ubiquitinated tau and
other proteins within neurons and by deposition of β-amyloid
(Aβ) in the extracellular compartments of gray matter (GM) and
in blood vessel walls as cerebral amyloid angiopathy (CAA) (1–3).
Tracer studies in experimental animals have shown that in CAA,
Aβ accumulates within the perivascular channels around capil-
laries and arteries that have been identified as interstitial fluid
(ISF) drainage pathways (4–11). Biochemical determinations have
shown that it is the levels of soluble Aβ in Alzheimer brains,
rather than the insoluble Aβ plaque load, that correlate with
severity of cognitive decline (12,13). These findings support the
hypothesis that the failure to eliminate Aβ along ISF drainage
pathways is a major factor in Aβ accumulation in the cortex and
in the AD pathogenesis.
In addition to the pathological changes in cerebral gray mat-
ter (GM) in AD, there is significant pathology in the underlying
cerebral white matter (WM). This is characterized by a relative
increase in ISF detectable through imaging and by histological
techniques (14). There is some evidence that vascular insuffi-
ciency may be involved in the pathogenesis of WM changes in AD
(15). However, there also is the distinct possibility that deposition
of Aβ in periarterial ISF drainage pathways may interfere with the
drainage of ISF from cerebral WM particularly as dilation of peri-
arterial spaces (état criblé) is a feature of white matter in AD.
Cerebral cortex and underlying WM both receive their blood
supply from branches of leptomeningeal arteries on the surface of
the brain. Extensive studies by Duvernoy and others (16) have
shown that arteries supplying the cerebral hemispheres penetrate
the cortex perpendicular to the surface and exhibit various
branching patterns and capillary fields within the cortex. Some
arteries supply the WM branch as they pass through the cortex,
but others do not. The arteries supplying the WM, therefore, are
derived from the same leptomeningeal arteries that supply the
overlying cortex and exhibit prominent CAA in AD.
CAA is a feature of a number of familial diseases and is pres-
ent in the brains of the majority if not all patients with AD (15). The
pattern of deposition of Aβ in capillary and artery walls correlates
with the ISF drainage pathways for interstitial fluid (17). A major
risk factor for CAA is possession of the ApoE ε4 genotype (18).
In the present study, we test the hypothesis that accumulation
of fluid in dilated periarterial ISF pathways in the WM in AD cor-
relates with severity of CAA, total Aβ load in the overlying cor-
tex, and Apo E genotype. In order to test this hypothesis, we
employed a novel strategy to analyze the topology of cerebrovas-
cular amyloid that took advantage of the extreme insolubility and
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resistance to disruption of amyloid deposits. This technique
involves the combined action of EDTA-SDS lysis and allows
detailed analysis of entire tufts of blood vessels spanning the GM.
Total Aβ peptide in GM and WM was quantified by immunoas-
say and ApoE genotyping by PCR. The dilation of perivascular
spaces in the WM was assessed by quantitative histology.
MATERIALS AND METHODS
Human Subjects—Brain Tissue
Brain tissue was obtained from the Brain Donation Program of the
Sun Health Research Institute. The cases were chosen to provide
a mixture of Apo E genotypes in both control nondemented (ND)
and AD groups. Characteristics of the cases in this study are given
in Table 1 and include age, Apo E genotype, density of neocorti-
cal neuritic plaques, Braak stage, and the National Institute of
Aging (NIA)-Reagan Institute diagnostic status. The terms
“high” and “intermediate” reflect the probability that symptoms
of dementia were due to AD. The mean age of ND cases was 83.2 y,
whereas that of AD cases was 82.2 y. Nondemented cases (n = 17)
comprised 8 females and 9 males while the AD cohort (n = 24)
contained 11 females and 13 males. Mean postmortem intervals
were 2.6 h for ND subjects and 2.8 h for AD subjects (difference
not significant on 2-tailed unpaired t-test). Leptomeninges were
dissected from the brain surface in the immediate post-mortem
period and stored at –80 °C. Cerebral hemispheres were cut in the
coronal plane as 8- to 10-mm thick slices. Right hemisphere slices
were frozen between sheets of dry ice and stored at –80 °C.
Tissue Processing
Left hemisphere slices were fixed in 4% paraformaldehyde for
48 h and then dissected into small tissue blocks for paraffin embed-
ding or larger blocks for microtome sectioning. Paraffin blocks
were sectioned at 5 µm and stained with hematoxylin and eosin
(H&E). Frozen sections (40 µm) were cut after cryoprotection in
2% dimethyl sulphoxide and 20% glycerol using a sledge-type
microtome, stained with H&E for general morphology and obser-
vation of WM. The lesions of AD were visualized using the
Campbell-Switzer and Gallyas stains. Brain sections also were
stained with 1% aqueous (wt/vol) Thioflavin-S (Sigma, St. Louis,
MO, USA) and rinsed 10 times with 70% ethanol to remove
unbound fluorochrome. The sections were mounted with Apa-
thy’s media and observed in an epifluorescent microscope.
Neuropathological Tissue and Patient Grading
Rarefaction of the WM in each cerebral lobe was graded on the
fraction of the centrum semiovale affected in thick (40 µm) quar-
ter-hemisphere sections stained with H&E (mild < 25%; moder-
ate 25% to 50%; severe > 50%). Individual percentages for each
lobe were converted to a numeric code (mild = 1; moderate = 2;
severe = 3) from which a mean score for each brain was
obtained. Neuritic plaque density in cerebral cortex was graded
according to criteria established by the Consortium to Establish
a Registry for Alzheimer’s Disease (1). Neurofibrillary tangles
were staged according to the method of Braak (2). The diagnosis
of AD was assigned whenever a subject was demented and had
at least a “moderate” plaque density. In addition, the protocol
developed by the NIA and the Reagan Institute (3) was used to
assign to each demented case a probability estimate that demen-
tia was due to AD.
Transmission Electron Microscopy
Cerebral cortex was taken fresh postmortem (1.2 h) from 3 AD
individuals, cut into small fragments (about 1 mm3), and
processed for electron microscopy. The specimens were fixed in
3% buffered glutaraldehyde and placed in 4% unbuffered osmium
tetroxide. The blocks were stained with 1% aqueous uranyl acetate
for 30 min, embedded in epon araldite resin, thin-sectioned, and
treated with lead citrate. The specimens were examined by a
Phillips 400 electron microscope at 80 kV.
Apolipoprotein E Genotyping
Genomic DNA was extracted from 50 mg of cerebellar tissue and
amplified by PCR using allele-specific oligonucleotide probes span-
ning positions 112 and 158 of the Apo E gene sequence. The PCR
products were HhaI-restricted, and the fragments were separated
by polyacrylamide electrophoresis. Genotypes were distinguished
on the basis of differential HhaI band fragment mobilities as
described by Hixson and Vernier (19).
Quantification of Cortical A by Immunoassay
Cerebral cortex fractions containing Aβ were purified by fast per-
formance liquid chromatography, and Aβ peptide was quantified
by immunoassay as described previously (20).
Preparation of Leptomeninges
Leptomeningeal tissue was prepared by partially transecting the
larger vessels to facilitate the release of entrapped blood. The spec-
imens then were rinsed 20 times with cold distilled water con-
taining 0.01% sodium azide to promote hemolysis and prevent
contamination. Blood vessels larger than 1-mm diameter were
removed. The cleaned, colorless membranes of leptomeninges and
the vascular network were then spread on disposable 15-cm Petri
dishes and dried in an oven at 50 °C for 18 h. The leptomeninges
were stained with 1% aqueous Thioflavin-S, as described above.
Preparation of Cerebral Cortex Vascular Tufts
From a slice of cerebrum (parietal lobe), approximately 8- to
10-mm thick, the GM was dissected from the underlying WM and
sectioned into small cubes measuring about 4 to 5 mm. A total of
25 pieces of cerebral cortex from each individual case were stirred
for approximately 24 h in 1 liter of lysis buffer (5% sodium dode-
cyl sulfate, 50 mM Tris HCl, 3 mM ethylenediaminetetraacetic
acid [EDTA], pH 7.4). After 24 h, pieces of the tissue were allowed
to settle and the lysis buffer decanted. A 2nd liter of lysis buffer
was added, and after complete brain tissue lysis, the white tufts
of blood vessels were isolated by filtration through a nylon mesh
(0.12 mm) mounted on a 10-cm diameter plastic embroidery
hoop. Those vessels retained on the nylon mesh were immedi-
ately released by vigorous shaking of the nylon mesh in 1 liter of
distilled water containing 0.01% sodium azide. The vessel prepa-
rations were filtered twice more using the same technique. After
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settling at room temperature for 16 h, the water phase was
removed by aspiration and the vascular suspension, approxi-
mately 30 mL in volume, was poured onto a Petri dish. The vas-
cular tufts were removed from the Petri dish and spread onto a
glass microscope slide. The blood vessel preparations were air
dried at 60 °C for 6 h, fixed in absolute ethanol for 30 min, rinsed
with distilled water, and Thioflavin-S stained. The stained prepa-
rations were observed using an epifluorescence microscope (Zeiss
Axiophot) equipped with a 450 to 490 nm excitation filter and a
520 nm barrier filter.
Morphometric Assessment of État Criblé–like Lesions
Brain tissue sections stained with H&E were viewed at 25×
magnification with the Leica DMLB microscope system (Leica
Table 1. Study Subjects
Case ID Age/Sex ApoE White matter score Plaque density Break stage NIA-Reagan Score
Control cases
1 94/F 3/3 1 Mod III ND
2 94/M 3/3 1 Mod III ND
3 85/M 3/3 1 None II ND
4 86/F 3/3 0 None III ND
5 89/F 3/3 1 Mod IV ND
6 76/F 3/3 1 Mod I ND
7 84/M 3/3 0 Mod III ND
8 78/M 3/3 1 None I ND
9 92/M 3/3 0 Sparse III ND
10 74/M 3/3 0 Mod IV ND
11 86/M 3/3 1 None II ND
21 80/F 3/4 1 Mod III ND
22 83/F 3/4 1 Mod II ND
23 86/F 3/4 1 Mod III ND
24 85/F 3/4 0 None III ND
25 69/M 3/4 1 Sparse I ND
26 73/M 3/4 0 None III ND
Alzheimer’s disease cases
51 93/F 3/3 0 Freq VI High
52 60/F 3/3 1 Freq VI High
53 90/F 3/3 2 Freq V High
54 96/F 3/3 3 Mod V High
55 80/F 3/3 3 Freq VI High
56 85/F 3/3 2 Freq V High
61 91/M 3/4 2 Freq V High
62 87/M 3/4 0 Freq V High
63 60/M 3/4 0 Freq VI High
64 84/M 3/4 1 Freq V High
65 89F 3/4 3 Freq V High
66 87/M 3/4 2 Freq V High
71 79/M 4/4 1 Mod V High
72 81/F 4/4 0 Freq VI High
73 79/F 4/4 3 Freq IV Int
74 68/M 4/4 1 Freq VI High
75 77/M 4/4 0 Freq VI High
76 87/M 4/4 2 Mod IV Int
77 79/M 4/4 2 Freq V High
78 80/M 4/4 3 Freq VI High
79 80/F 4/4 1 Freq VI High
80 93/F 4/4 2 Freq VI High
81 84/M 4/4 1 Freq VI High
82 83/M 4/4 1 Freq VI High
Mod, moderate; Freq, frequent; Int, intermediate; ND, nondemented.
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Microsystems AB, Ernst-Leitz-Strasse, Wezlar, Germany) with a
100 W transmitted light source. The whole area of each slide was
scanned for evidence of dilated perivascular spaces in the WM;
their outlines were digitized with an Optronics Magnafire SP
camera (model s99805) using the Optronics Magnafire SP soft-
ware program (Optronics, Goleta, CA) and stored in TIF format.
All measurements were carried out using Image-Pro Express soft-
ware v. 4.0 (Media Cybernetics, Silver Springs, MD), which was
calibrated to 25× magnification. The diameter of each enlarged
perivascular space, that is, larger than 1 mm in perimeter, and  the
blood vessel within were measured using the straight line tool
and computer mouse. The data were transferred to Microsoft
Excel®, and the mean ratios of perivascular space diameters to
blood vessel diameters for each case were calculated and then
grouped by ApoE genotype and diagnosis.
RESULTS
Cerebral Amyloid Angiopathy
A detailed analysis of entire tufts of cerebral vessels spanning the
GM of the cerebral cortex was performed on preparations of cor-
tex after complete cell lysis by the combined action of EDTA-SDS.
No vascular amyloid was detected by Thioflavin-S–staining in
control brains, but amyloid deposits were present in AD brains.
All vessels less than 500 µm in diameter had amyloid deposits
(Figure 1A and 1B). The deposits of amyloid tend to disappear in
larger leptomeningeal arteries. The arteriolar and capillary ves-
sels demonstrated a unique abundance of discreet ‘core-like’ amy-
loid deposits firmly attached to the vessel wall and, in many
cases, the cores appeared to be fused together (see Figure 1C
and 1D). All the spherical amyloid cores associated with capillar-
ies displayed a brush-like surface. On average, there was a mod-
erate amount of amyloid associated with the vessels of the cere-
bral cortex in AD patients with ApoE ε3/ε3 and ε3/ε4 genotypes.
However, the most severely affected individuals, in terms of amy-
loid load, were those with ApoE ε4/ε4 genotype (see Figure 1).
Whole mount preparations of all ε4/ε4 AD subjects revealed an
overwhelming amount of vascular amyloid in the cerebral cortex.
Electron microscopy of the GM arteries showed a virtual disap-
pearance of smooth muscle cells from artery walls containing
large amounts of amyloid and obliteration of the perivascular
spaces (Figures 1A and 2B, 2C, and 2D).
Figure 1. Thioflavin-S–stained whole-mounted tufts of cortical vessels after complete brain parenchyma lysis by EDTA-SDS. A: Ring-like amyloid deposits
in leptomeningeal arterial walls. The pattern of deposition follows the orientation of the smooth muscle cells. Magnification 25×. B: Tufts of cortical-
penetrating arteries heavily loaded with amyloid from an AD patient with Apo E ε4/ε4 genotype. The perivascular spaces are probably occluded in
the saturated amyloid vessels, and in some cases may be totally destroyed by the encroaching amyloid, thus hindering the elimination of interstitial
fluid. Magnification 100×. C: Cortical arterioles and capillaries showing an abundant deposition of amyloid cores, in an individual with Apo E ε4/ε4
genotype, at different stages of development that are intimately linked to the basal laminae of the vessels. The profuse deposits of amyloid at the
arteriolar/capillary junction may block the openings of the perivascular spaces that drain the brain’s interstitial fluid. Magnification 200×. D: At a 
higher magnification, each of the fluorescent blebs represents a fully developed globular deposit of amyloid evenly spread around and constricting
the microvessel, probably creating areas of ischemia and alterations in blood-brain barrier. Magnification 400×.
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In AD cases, most of the arteries in the leptomeninges, up to
a diameter of 500 µm, demonstrated a heavy load of ring-like
deposits similar to those seen in the cerebral cortical arteries (see
Figure 1A). However, in those individuals with ApoE ε3/ε3 and
ε3/ε4 genotypes, the distribution of amyloid in the leptomen-
ingeal vessels was segmental; that is, portions of artery with a
heavy load of amyloid were interspersed with lengths of vessel
that were free of amyloid. As in the cerebral cortex, those individ-
uals with ApoE ε4/ε4 genotypes had a more prominent amount of
vascular amyloid involving almost all the small (< 500 µm) lep-
tomeningeal arteries. As the leptomeningeal arteries increased in
diameter, the amyloid load gradually declined to isolated streaks
associated with the more peripheral layers of the tunica media.
The large branches of the circle of Willis were entirely devoid of
microscopically visible (Thioflavin-S positive) amyloid. Occasion-
ally in the leptomeninges, areas of old microhemorrhages were
revealed by the presence of hemosiderin deposits along vessels
burdened with amyloid (data not shown).
Dilation of Perivascular Spaces in AD
Macroscopic inspection of brain sections from ND controls (Fig-
ure 3A) and from individuals with AD (see Figure 3B) revealed a
Figure 2. Electron micrographs of a normal cortical artery and of arteries destroyed by amyloid deposition in 3 AD cases homozygous for Apo E ε4/ε4.
A: An electron micrograph of a small normal cortical artery. The endothelial cells are joined by tight junctions (small arrows) that participate in the
blood-brain barrier. Both their nuclei and thin cytoplasm have a normal morphology. These cells are in contact with the subjacent basal lamina
(opposing large arrows). The smooth muscle cells (white arrows) have a normal-looking fibrillar cytoplasm, and a typical nucleus is seen on the left
margin of the photograph. The thin periarterial space (black arrowheads) contains the extracellular matter of the adventitia and is on its outer mar-
gin limited by a single layer of pial cells (8). Magnification 5500×. B and C: Small cortical arteries surrounded by heavy amyloid deposition. The
endothelial cells are apparently swollen. The tight junctions have an abnormal morphology (black arrows). The dense amyloid deposits are fused with
the basal lamina of the vascular cells. The myocytes have vanished or are reduced to a collection of cellular debris (white arrows) that is enclosed
by concentric layers and peripheral wisps of amyloid surrounded by a large amount of tissue debris (open stars). The tunica adventitia, perivascular
spaces, and the glia limitans have degenerated as the result of heavy amyloid deposition. Magnification 4300× and magnification 3500×, respec-
tively. D: An abnormal cortical artery with abundant fine wisps of amyloid perpendicular to the main axis of the vessel. The amyloid bundles, inter-
spersed by large amounts of cellular debris, pushed out the glia limitans (open arrows). On the left margin of the micrograph, the amyloid has
destroyed the glia limitans invading the surrounding cortical tissue (black stars). All myocytes and the tunica adventitia have been replaced by amy-
loid fibrils and debris. Magnification 2000×. One may assume from the extensive vascular pathology that the delivery of oxygen and nutrients as well
as arterial contractility are largely compromised.
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large number of dilated perivascular spaces in the WM of AD
cases. The dilated perivascular spaces were more prominently
displayed by light microscopy (Figure 4). Very few dilated peri-
vascular spaces were seen in control material. Areas of rarefaction
in the WM were more abundant in AD than in the control cases.
As shown in Table 1, the average WM rarefaction score was sig-
nificantly higher in the AD cases (mean = 1.5, range 0 to 3) than in
the control cases (mean = 0.65, range 0 to 1; P = 0.004).
Quantitation of A and Dilated Perivascular Spaces in
the White Matter
Quantitation of total cortical Aβ (Aβ 40 and Aβ 42) by immuno-
assay from ApoE ε4/ε4 AD subjects yielded an average of 54 µg/g
of tissue with 2 of 3 of the Aβ peptides ending at residue 42; this
is supported by our previous observations (21). Total Aβ in the
cortex quantified by immunoassay in the ApoE ε3/ε4 and ε3/ε3
cohorts showed mean values of 26 and 35 µg/g of tissue, respec-
tively, with a predominance of Aβ 42. In these cases, core-like and
ring-like amyloid deposition prevailed, resembling the type 2
deposits described by Thal and others (22). In contrast to the
AD subjects, the total Aβ in control individuals carrying the
ApoE ε3/ε3 and ε3/ε4 genotypes only amounted to 3 and 4 µg/g
of tissue, respectively.
Total Aβ in GM of AD patients was 12 times greater than in
control cases (Figure 5A). The amount of Aβ was significantly
higher in the AD patients with ApoE ε4/ε4 than in those AD indi-
viduals with ApoE ε3/ε4 and ε3/ε3 genotypes (see Figure 5A).
Likewise, the number of perivascular spaces in WM as well as the
ratio of the diameters of perivascular spaces over the diameters of
centrally located blood vessels were significantly higher in the AD
cohort when compared with ND controls (see Figure 5B and 5C).
When the AD cohorts were grouped by ApoE genotype, there was
a positive correlation between the average number of enlarged
perivascular spaces and the average cortical concentration of Aβ
(see Figure 5D). The ratio of the perivascular space diameter over
blood vessel diameter also had a significant positive correlation
with the cortical Aβ concentration (see Figure 5E) and the number
of enlarged perivascular spaces (see Figure 5F). In contrast to the
ND population, the AD cohort had an increased load of cortical Aβ,
a higher count of distended perivascular spaces (état criblé–like
lesions). In addition,  the distended perivascular spaces were larger
relative to the size of their respective blood vessels. Furthermore,
individuals with the ApoE ε4/ε4 genotype have more of the afore-
mentioned pathology than those with 1 or no ApoE ε4 alleles.
Relationship Between Dilated Perivascular 
Spaces and Cerebral Atrophy
We also explored the possibility that enlargement of perivascular
spaces may result from retraction of WM due to overall brain
atrophy. Because there is a significant difference in brain size
between genders, these cohorts were evaluated separately. No
correlation was found between brain weight and the average
number of enlarged perivascular spaces in the WM or between
brain weight and the average ratio of perivascular space diameter
to blood vessel diameter.
DISCUSSION
Our results suggest that there is a correlation between the sever-
ity of cortical and leptomeningeal CAA, the amount of Aβ in the
cerebral cortex, and the accumulation of ISF in dilated perivascu-
lar spaces (état criblé–like lesions) in AD WM. Conventional his-
tological techniques do not allow full evaluation of CAA. By
stripping the leptomeningeal arteries from the cortex and then
removing all traces of blood and Thioflavin-S staining, a clear pic-
ture of the extent of amyloid involvement of cerebral vessels
emerges. Leptomeningeal arteries with CAA have a ring-like pat-
tern of Aβ deposition that follows the orientation of smooth mus-
cle cells within the media. A similar pattern is seen in the larger
cortical arteries. A ring-like distribution of Aβ in which whole
Figure 3. Hematoxylin- and eosin-stained superior frontal gyrus and under-
lying WM sections from an ND individual and an AD case. Magnification:
about 2.5×. A: Cerebral section from a 74-y-old ND individual with ApoE
ε3/ε3 genotype, who died as the result of metastatic prostate cancer. The
WM appears homogeneously stained without noticeable dilated periar-
terial spaces. B: Shows a section from an 80-y-old AD patient with ApoE
ε4/ε4 genotype. The numerous arteries with enlarged perivascular spaces
are evident throughout the entire extent of the WM, whereas the GM is
comparatively free of these alterations. The paler blotches in the WM rep-
resent areas of myelin rarefaction.
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lengths of vessel are virtually replaced by Aβ is seen in smaller
arteries and arterioles. Core-like deposits of Aβ form in capillary
walls, and they are often arranged in confluent rows. It is difficult
to assess the effect of arterial and capillary CAA on the blood sup-
ply of the cerebral cortex. We observed that some of the capillar-
ies are occluded by amyloid deposits. In other studies, capillary
lumina remained patent even in the presence of heavy deposition
of Aβ in the capillary basement membrane (17). Even if occlusion
did occur, extensive capillary anastomoses exist within the cortex
(16), making any physiological effects difficult to predict.
Figure 4. Perivascular spaces in Alzheimer’s disease white matter. Row A: The fine periarterial spaces are not normally visible at light microscopic level.
Magnifications: left and center 100×; right 200×. Row B: The periarterial spaces appear to be slightly dilated. Magnifications: left 200×; center and right
100×. Rows C, D, and E demonstrate a series of severely distended perivascular spaces. The centrally located arteries apparently have a normal mor-
phology. All captions were taken at 100×. All histological slides were stained with hematoxylin and eosin.
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Figure 5. Quantitative and statistical analyses among the 3 variables investigated in this study: cortical Aβ concentrations, number of dilated perivas-
cular spaces (état criblé–like lesions), and ratio of perivascular space diameter/blood vessel diameter. In the 3 left panels,  and  histograms rep-
resent the total numbers of ND and AD individuals and these populations divided by Apo E genotype, respectively. The 3 panels on the right side of
the figure demonstrate the linear correlations and P values among the 3 studied variables. A: The total levels of cortical Aβ in ND and AD subjects. 
P value represents the 2-tailed unpaired Student t-test probability. * and ** represent P < 0.05 and P < 0.01, respectively, in post-hoc analysis (Newman-
Keuls Multiple Comparison Test) after 1-way analysis of variance demonstrated that there was a significant difference among the AD subgroups. 
B: The average number of WM enlarged perivascular spaces (état criblé–like lesions) in the ND and AD groups. P value represents the 2-tailed
unpaired Student t-test probability. C: Mean ratios of perivascular space diameter/blood vessel diameter observed in ND and AD cohorts. P value
represents the 2-tailed unpaired Student t-test probability. D: Linear correlation (R = 0.97) between the mean number of WM enlarged perivascular
spaces and average levels of cortical Aβ when the AD and control subjects were grouped by Apo E genotype. E: Linear correlation between the
ratio of perivascular space diameter to blood vessel diameter and the total levels of cortical Aβ (R = 0.55; P < 0.001). F: Linear correlation between
the mean number of WM enlarged perivascular spaces and the ratio of perivascular space diameter to blood vessel diameter (R = 0.70; P < 0.001).
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Accumulation of Aβ in the cerebral cortex and cerebral vessels
correlates with dilation of perivascular spaces in the underlying
WM. Thus the number of dilated perivascular spaces in Alzheimer
brains is significantly greater than in ND individuals, and the
number of dilated spaces is proportional to the level of Aβ in the
overlying cortex and associated arteries. Furthermore, Aβ concen-
trations in the cortex were higher for ApoE ε4/ε4 cases than in
other ApoE genotypes. Total Aβ load in the WM was much higher
in Alzheimer’s disease than in ND individuals, (20) which sug-
gests that Aβ elimination from the WM is reduced in AD.
In the present and previous investigations, we have observed
that the amount of Aβ deposited along the cortical and leptomen-
ingeal vessels directly correlates with Apo E genotype (12). In AD,
the relative amount of Aβ in these vessels decreases as follows:
ε4/ε4 >> ε3/ε3 > ε3/ε4. It appears that slowly evolving occlusion of
the perivascular spaces in the cortical and leptomeningeal arteries
results in dilation of perivascular spaces in the WM, that is, état
criblé, and subclinical chronic edema of the WM parenchyma. The
extent of the edema is related to tissue compliance, which is greater
in the WM than in the GM and greater in the deep WM than in the
superficial WM (23). In humans, the WM of the centrum semiovale
is supplied by long penetrating medullary arteries that are a con-
tinuation of cortical perforating vessels derived from the lep-
tomeningeal arteries (16) and by perforating arteries directly
derived from the circle of Willis (24).
Little attention has been paid in the past to the effects of CAA
on WM in AD despite the evidence from Duvernoy and others (16)
that branches of leptomeningeal arteries supply the cerebral WM
as well as the cortex. Although CAA is rarely seen in arteries in the
WM, impedance of ISF flow from the WM still could occur due to
involvement of leptomeningeal and cortical arteries by CAA. It is
of interest for the future development of immunotherapy for
Alzheimer’s disease that some of the patients treated by Aβ
immunization develop severe rarefaction and significant increase
of ISF in the WM. In 1 post-mortem case, the WM edema was
accompanied by severe CAA (25).
État criblé has been classically described as the consequence
of dilation of perivascular spaces due to enlargement, distortion,
and formation of loops in cerebral arterioles and small arteries
that result from aging, hypertension, or a combination of both fac-
tors. In our AD cohort, we rarely observed the characteristic thick-
ening and hyalinosis of artery walls commonly seen in the WM as
the état criblé associated with hypertension (14). Rather, in the
état criblé–like condition of AD, most of the WM arteries appear
to have a normal configuration.
The état criblé quantified in the present study resembles the
dilated perivascular spaces occasionally seen in the WM of younger
individuals, with or without an accompanying dementia (26).
Dilated perivascular spaces also are seen in the GM of the basal
ganglia as état lacunaire but rarely if at all in the cortex. Giant
Figure 6. Diagram suggesting the morphological changes that lead to enlargement of WM perivascular spaces. A: Under normal conditions, the
brain’s interstitial fluid is collected by the patent periarterial spaces around the blood vessels of the WM, GM, and leptomeninges. B: The lep-
tomeningeal and perforating cortical arteries supplying the brain GM and WM are surrounded by heavy amyloid deposits that destroy the vascular
walls and block the perivascular spaces at the level of the cerebral cortex and leptomeninges. This obstruction results in WM congestion and stasis
of interstitial fluid with simultaneous dilation of the WM perivascular spaces. The greater density and rigidity and lesser compliance of the GM matter
leave this tissue substantially less affected than the WM.
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lacunes in the basal ganglia or in the mid-brain may obstruct CSF
flow and result in hydrocephalus (27). It has been suggested that
such lacunes are due to blockage of ISF drainage pathways (28).
The anatomy of perivascular spaces of arteries in the WM appears
to be similar to that of arteries in the basal ganglia but differs from
cortical vessel (26,28). Thus the structure of the perivascular spaces
may play a key role in the preferential formation of état lacunaire
in the basal ganglia and état criblé in the WM.
We have found that the WM of AD subjects is in general more
fragile and softer than the WM of control elderly individuals,
which under pressure has a higher resilience (20). From a bio-
chemical viewpoint, the AD WM has significantly less cholesterol
and myelin proteins and an elevated amount of Aβ peptides, even
though parenchymal amyloid deposits and obvious perivascular
amyloid accumulations are lacking (20). Ultrastructural studies
have demonstrated that the AD WM, relative to controls, has a
decreased number of axons and myelin levels, which are accom-
panied by the presence of large astrocytes with swollen-like cyto-
plasm (B Bohrmann and AE Roher, unpublished results). The
astrocytes, by virtue of being interconnected by gap junctions,
apparently regulate the amount of water and ions present in the
extracellular space of relatively large areas of the brain (29). We
postulate that obstruction of ISF drainage caused by deposition of
amyloid in cortical and leptomeningeal blood vessel walls not
only dilates the perivascular spaces in the WM and produces ISF
stasis but also forces the sub-ependymal astrocytes to eliminate
excessive amounts of water into the ventricles. The production of
CSF by the choroid plexi in a normal adult is around 600 mL/d,
whereas in AD patients it is substantially reduced to about
300 mL/d (30). In view of these observations, it is possible that the
remarkable enlargement of the lateral ventricles in AD results
from, among other factors, the sustained drainage of extra fluid
from WM into the lateral ventricles. Thus, the ventricles may act
as a sink for interstitial WM fluid that could not be cleared
through the amyloid-obstructed perivascular spaces.
In conclusion, the results of this study strongly support our
hypothesis that compromised drainage of interstitial fluid from
the WM in AD is due to blockage of the cortical and leptomenin-
geal perivascular spaces by amyloid deposition, thereby causing
dilatation of perivascular spaces in the WM (Figure 6). Examina-
tion of AD vessel topology has clarified the pattern of vascular
amyloid deposition and suggests a possible pathophysiological
chain of events. Our analyses suggest that dysfunctional Aβ trans-
port and attendant vascular amyloid deposition results in an
impairment of brain fluid dynamics and leads to some of the dele-
terious changes linked to advanced AD. Fundamental structural
changes in the integrity of the arterial tree may be the key factor
initiating amyloid deposition (31). As the stability of the microvas-
culature and the blood-brain barrier declines with normal aging or
through ischemic and traumatic injury, amyloid nucleation sites
become available in the vasculature. Continued and relentless
accretion of Aβ along the cortical and leptomeningeal vessels may
result in the ultimate impairment of the entire regional circulation,
causing cerebral ischemia, stasis of interstitial fluid, and chronic
subclinical edema of WM. These findings underscore the complex
and multifactorial nature of AD pathology.
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